Full Text View
Tabular View
No Study Results Posted
Related Studies
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
This study has been terminated.
( See termination reason in detailed description. )
Study NCT01162889   Information provided by Pfizer

First Received on June 9, 2010.   Last Updated on March 13, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Placebo SC Injection
ATR-107 (PF-05230900) SC Injection
ATR-107 (PF-05230900) IV Infusion
Placebo IV Infusion
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services